| 2015-1-C | GTN 2015-1-C | Antianginal Agents |
| 2013-2-C | GTN 2013-2-C | Antianginal Agents |
| 2013-1 | GTN 2013-1 | Antianginal Agents |
| 2010-2 | GTN 2010-2 | Antianginal Agents |
| 2008-1 | GTN 2008-1 | Antianginal Agents |
| 2007-1 | GTN 2007-1 | Antianginal Agents |
| 2004-2 | GTN 2004-2 | Antianginal Agents |
| 2005-1 | Nitric Oxide 2005-1 | Antianginal Agents |
| 2016-2-B | Adenosine 2016-2-B | Antiarrhythmics |
| 2012-2 | Adenosine 2012-2 | Antiarrhythmics |
| 2011-1 | Adenosine 2011-1 | Antiarrhythmics |
| 2005-2 | Adenosine 2005-2 | Antiarrhythmics |
| 2003-1 | Adenosine 2003-1 | Antiarrhythmics |
| 2015-1-A | Amiodarone 2015-1-A | Antiarrhythmics |
| 2013-2-A | Amiodarone 2013-2-A | Antiarrhythmics |
| 2011-1 | Amiodarone 2011-1 | Antiarrhythmics |
| 2010-1 | Amiodarone 2010-1 | Antiarrhythmics |
| 2006-1 | Amiodarone 2006-1 | Antiarrhythmics |
| 2018-1-A | Digoxin 2018-1-A | Antiarrhythmics |
| 2015-2-C | Digoxin 2015-2-C | Antiarrhythmics |
| 2011-1 | Digoxin 2011-1 | Antiarrhythmics |
| 2009-1 | Digoxin 2009-1 | Antiarrhythmics |
| 2006-1 | Digoxin 2006-1 | Antiarrhythmics |
| 2004-2 | Digoxin 2004-2 | Antiarrhythmics |
| 2008-2 | Flecainide 2008-2 | Antiarrhythmics |
| 2011-1 | Lignocaine 2011-1 | Antiarrhythmics |
| 2005-1 | Lignocaine 2005-1 | Antiarrhythmics |
| 2004-2 | Lignocaine 2004-2 | Antiarrhythmics |
| 2016-1-C | Propranolol 2016-1-C | Antiarrhythmics |
| 2006-2 | Sodium Channel Blockers 2006-2 | Antiarrhythmics |
| 2012-1 | Sotalol 2012-1 | Antiarrhythmics |
| 2015-2-C | Verapamil 2015-2-C | Antiarrhythmics |
| 2021-0 | ACE inhibitors 2021-0 | Antihypertensives |
| 2019-1-C | ACE inhibitors 2019-1-C | Antihypertensives |
| 2010-2 | ACE inhibitors 2010-2 | Antihypertensives |
| 2016-2-B | Angiotensin II Receptor Blockers 2016-2-B | Antihypertensives |
| 2008-1 | Angiotensin II Receptor Blockers 2008-1 | Antihypertensives |
| 2009-1 | Antihypertensives 2009-1 | Antihypertensives |
| 2014-1-A | Captopril 2014-1-A | Antihypertensives |
| 2005-2 | Captopril 2005-2 | Antihypertensives |
| 2003-1 | Captopril 2003-1 | Antihypertensives |
| 2011-1 | Hypertensive emergencies 2011-1 | Antihypertensives |
| 2017-2-A | Prazosin 2017-2-A | Antihypertensives |
| 2017-2-B | Ramipril 2017-2-B | Antihypertensives |
| 2023-1 | Betablockers 2023-1 | Betablockers |
| 2007-1 | Betablockers 2007-1 | Betablockers |
| 2005-1 | Betablockers 2005-1 | Betablockers |
| 2018-1-A | Metoprolol 2018-1-A | Betablockers |
| 2016-2-B | Metoprolol 2016-2-B | Betablockers |
| 2014-2-A | Metoprolol 2014-2-A | Betablockers |
| 2010-1 | Metoprolol 2010-1 | Betablockers |
| 2013-1 | Propranolol 2013-1 | Betablockers |
| 2004-2 | Propranolol 2004-2 | Betablockers |
| 2011-2 | Calcium Channel Blockers 2011-2 | Calcium Channel Blockers |
| 2009-2 | Calcium Channel Blockers 2009-2 | Calcium Channel Blockers |
| 2006-2 | Calcium Channel Blockers 2006-2 | Calcium Channel Blockers |
| 2017-2-C | Verapamil 2017-2-C | Calcium Channel Blockers |
| 2013-1 | Verapamil 2013-1 | Calcium Channel Blockers |
| 2007-2 | Acetazolamide 2007-2 | Diuretics |
| 2017-1-B | Frusemide 2017-1-B | Diuretics |
| 2014-2-B | Frusemide 2014-2-B | Diuretics |
| 2011-2 | Frusemide 2011-2 | Diuretics |
| 2010-2 | Frusemide 2010-2 | Diuretics |
| 2008-1 | Frusemide 2008-1 | Diuretics |
| 2004-2 | Frusemide 2004-2 | Diuretics |
| 2015-2-D | Mannitol 2015-2-D | Diuretics |
| 2007-1 | Osmotic Diuretics 2007-1 | Diuretics |
| 2015-2-D | Thiazide Diuretics 2015-2-D | Diuretics |
| 2006-2 | Thiazide Diuretics 2006-2 | Diuretics |
| 2003-2 | Antiplatelet agents 2003-2 | Drugs affecting thrombosis |
| 2017-1-A | Clopidogrel 2017-1-A | Drugs affecting thrombosis |
| 2006-2 | Clopidogrel 2006-2 | Drugs affecting thrombosis |
| 2005-1 | Clopidogrel 2005-1 | Drugs affecting thrombosis |
| 2014-2-B | Heparin 2014-2-B | Drugs affecting thrombosis |
| 2012-1 | Heparin 2012-1 | Drugs affecting thrombosis |
| 2008-1 | Heparin 2008-1 | Drugs affecting thrombosis |
| 2006-1 | Heparin 2006-1 | Drugs affecting thrombosis |
| 2003-1 | Heparin 2003-1 | Drugs affecting thrombosis |
| 2016-1-A | Rivaroxaban 2016-1-A | Drugs affecting thrombosis |
| 2017-2-A | Thrombolytics 2017-2-A | Drugs affecting thrombosis |
| 2012-2 | Tissue Plasminogen Activator 2012-2 | Drugs affecting thrombosis |
| 2009-2 | Tissue Plasminogen Activator 2009-2 | Drugs affecting thrombosis |
| 2007-1 | Tissue Plasminogen Activator 2007-1 | Drugs affecting thrombosis |
| 2012-2 | Warfarin 2012-2 | Drugs affecting thrombosis |
| 2012-1 | Warfarin 2012-1 | Drugs affecting thrombosis |
| 2011-1 | Warfarin 2011-1 | Drugs affecting thrombosis |
| 2009-2 | Warfarin 2009-2 | Drugs affecting thrombosis |
| 2006-1 | Warfarin 2006-1 | Drugs affecting thrombosis |
